Literature DB >> 29168119

Clinical and biological significance of a - 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma.

Baozhen Zhang1, Jing Zhou2, Zhaojun Liu2, Liankun Gu2, Jiafu Ji3, Woo Ho Kim4, Dajun Deng5.   

Abstract

BACKGROUND: CDH1 germline mutations lead to hereditary diffuse gastric carcinomas. However, it is unclear whether genetic variations in the CDH1 promoter affect the progression of sporadic gastric carcinomas (SGCs).
METHODS: SGC patients in two independent cohorts with follow-up data were enrolled. The CDH1 genotypes, including the - 73A > C polymorphism (rs28372783), were determined by PCR sequencing. The CDH1 promoter activity was determined using reporter assays. SNAIL bound to CDH1 alleles was determined by chromatin immunoprecipitation primer extension PCR. CDH1 DNA methylation was determined by bisulfite-based PCR analyses.
RESULTS: Kaplan-Meier analyses showed that the overall survival (OS) of the - 73C/C patients was significantly longer than that of the - 73A/C or - 73A/A patients in a Chinese cohort [n = 526; hazard ratio 0.68 (95% CI 0.47-1.00)], which was validated in an independent Korea cohort [n = 215; hazard ratio 0.49 (95% CI 0.26-0.94)]. Moreover, the transcription activity of the - 73C alleles was significantly higher than that of the - 73A alleles in vitro and in vivo. The ratio of SNAIL recruited to the promoter regions of the - 73C and - 73A alleles was 1:10, indicating a strong influence of this polymorphism on the recruitment of SNAIL to the flanking E-box. The prevalence of DNA methylation of the CpG island and shore within the promoter of the - 73C allele was much less than that of the - 73A allele in both gastric tissues and cancer cell lines.
CONCLUSION: The - 73A > C variation may lead to differences in the overall survival of SGC patients and allele-specific repressions of CDH1.

Entities:  

Keywords:  Allele-specific repression; CDH1; DNA methylation; Gastric carcinoma; Overall survival; SNAIL; SNP

Mesh:

Substances:

Year:  2017        PMID: 29168119     DOI: 10.1007/s10120-017-0778-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  34 in total

1.  Combined bisulfite restriction analysis (COBRA).

Authors:  Cindy A Eads; Peter W Laird
Journal:  Methods Mol Biol       Date:  2002

2.  [Analysis of demethylation-related HPV16 reactivation by DHPLC-primer extension assay].

Authors:  Hua Bai; Da-Jun Deng
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2007-06

3.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

4.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Authors:  W M Grady; J Willis; P J Guilford; A K Dunbier; T T Toro; H Lynch; G Wiesner; K Ferguson; C Eng; J G Park; S J Kim; S Markowitz
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.

Authors:  Bárbara do Nascimento Borges; Erivelton da Silva Santos; Carlos Eduardo Matos Carvalho Bastos; Laine Celestino Pinto; Nilson Praia Anselmo; Juarez Antônio Simões Quaresma; Danielle Queiroz Calcagno; Rommel Mario Rodríguez Burbano; Maria Lúcia Harada
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

6.  Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.

Authors:  Giovanni Corso; Joana Carvalho; Daniele Marrelli; Carla Vindigni; Beatriz Carvalho; Raquel Seruca; Franco Roviello; Carla Oliveira
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

7.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.

Authors:  Carmen J Marsit; Marshall R Posner; Michal D McClean; Karl T Kelsey
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

9.  Landscape of X chromosome inactivation across human tissues.

Authors:  Taru Tukiainen; Alexandra-Chloé Villani; Angela Yen; Manuel A Rivas; Jamie L Marshall; Rahul Satija; Matt Aguirre; Laura Gauthier; Mark Fleharty; Andrew Kirby; Beryl B Cummings; Stephane E Castel; Konrad J Karczewski; François Aguet; Andrea Byrnes; Tuuli Lappalainen; Aviv Regev; Kristin G Ardlie; Nir Hacohen; Daniel G MacArthur
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

10.  Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Masanori Goto; Moriya Iwaizumi; Hiroyuki Konno; Hideki Kataoka; Masami Yamada; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

View more
  2 in total

1.  DNA Methylation and SNPs in VCX are Correlated with Sex Differences in the Response to Chronic Hepatitis B.

Authors:  Xue-Qing Hu; Yuan Zhou; Jian Chen; Yu Zhao; Yi-Yu Lu; Qi-Long Chen; Yuanjia Hu; Yi-Yang Hu; Shi-Bing Su
Journal:  Virol Sin       Date:  2019-06-03       Impact factor: 4.327

2.  Promotion of rs3746804 (p. L267P) polymorphism to intracellular SLC52A3a trafficking and riboflavin transportation in esophageal cancer cells.

Authors:  Lin Long; Xiao-Xiao Pang; Fa-Min Zeng; Xiu-Hui Zhan; Ying-Hua Xie; Feng Pan; Wei Wang; Lian-Di Liao; Xiu-E Xu; Bin Li; Li-Dong Wang; Zhi-Jie Chang; En-Min Li; Li-Yan Xu
Journal:  Amino Acids       Date:  2021-07-05       Impact factor: 3.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.